The pharmaceutical industry is poised for a dynamic year in 2025. A confluence of positive trends suggests a brighter outlook ahead after declining earnings in recent years. According to ZS consultant Cody Powers, lower interest rates could increase investment in biopharma, boosting research and development (R&D) into promising new indications,…
Today’s pharmaceutical market is facing the challenges of inflation, government-imposed drug price caps and waning demand for COVID-19 vaccines.…
Rare earths prices saw some gains in May 2024, fueled by positive sentiment over consumer demand in China. While…
Flynn Gold (FG1:AU) has announced Flynn Expands Key Gold Targets at Golden Ridge, NE Tasmania Download the PDF here.…
Mali’s government has begun seizing gold stockpiled at Barrick Gold’s (TSX:ABX,NYSE:GOLD) Loulo-Gounkoto mine, enforcing a provisional order issued last…
Global markets were turbulent this week on speculation about US President-elect Donald Trump’s trade policies. Initial gains on Monday…
High-Tech Metals (HTM:AU) has announced Appointment of Chief Executive Officer Download the PDF here. This post appeared first on…
Overview Mining in Ontario is big business. In 2021, Ontario’s mining industry produced roughly C$11.1 billion worth of minerals,…
Sarama Resources Ltd. (“Sarama” or the “Company”) (ASX:SRR, TSX- V:SWA) is pleased to advise that it has executed a…